© 2004 by Oxford University Press
© 2004 Oxford University Press
CORRESPONDENCE |
RESPONSE: Re: Human Papillomavirus in Oral Exfoliated Cells and Risk of Head and Neck Cancer
Affiliation of authors: Department of Epidemiology, College of Public Health (EMS), VAMC and Department of Pathology, Carver College of Medicine (THH, LPT), University of Iowa, Iowa City
Correspondence to: Elaine M. Smith, PhD, MPH, Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, IA 52242 (e-mail: elaine-smith@uiowa.edu)
| The first 10% of the full text of this article appears below. |
Dr. Castles caution regarding human papillomavirus high-risk (HPV-HR) types in head and neck cancer is, in our opinion, unduly pessimistic. Although he recognizes that our oral HPV testing was more accurate for the detection of head and neck cancer (HNC), he lumps our results (1) with those of a study by the IARC consortium (2) that reported lower HPV-HR prevalence in case and control subjects alike. We believe that combining the
Related Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2004 96: 1181-1182.